Cargando…
Three Cases of Hemodialysis Patients Receiving High-Dose Ceftriaxone: Serum Concentrations and Its Neurotoxicity
Autores principales: | Inoue, Yui, Doi, Yohei, Arisato, Tetsuya, Sugioka, Sayaka, Koga, Kenichi, Nishioka, Keisuke, Sugawara, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733829/ https://www.ncbi.nlm.nih.gov/pubmed/29270508 http://dx.doi.org/10.1016/j.ekir.2017.03.009 |
Ejemplares similares
-
Hydroxychloroquine-Associated Hypoglycemia in Hemodialysis Patients With COVID-19
por: Dirim, Ahmet Burak, et al.
Publicado: (2020) -
Collateral Damage—The Risks of Central Venous Hemodialysis Catheters
por: Roper, Tayeba, et al.
Publicado: (2020) -
Dabigatran Toxicity in Acute Kidney Injury: Hemodialysis and Idarucizumab Required
por: McBride, Lucy, et al.
Publicado: (2018) -
Vascular Ehlers-Danlos Syndrome Diagnosed in a Patient Initiating Hemodialysis
por: Ouchi, Haruki, et al.
Publicado: (2019) -
Clinical Use of Angiogenic Factors in Managing a Pregnant Woman on Hemodialysis to Term
por: Shanmugalingam, Renuka, et al.
Publicado: (2021)